At the Intersection of Science and Law
by DLA Piper
November 16, 2024 6:15 am
In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences team explore the connection between science and the law in areas that include AI and drug discovery, mRNA technology, and the regulatory implications of new drugs and devices.
Recent Episodes
Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches
8 months agoLife sciences companies and the risks posed by the mifepristone litigation
2 years agoTrade secrets protection in the life sciences sector
2 years agoCross-border considerations for privacy in clinical trials
2 years agoGlobal Life Sciences Supply Chain Insights
3 years agoAI risk assessments: Future-proofing your innovation when rules can change mid-game
3 years agoThe rise of global telehealth
3 years agoAdvising the advisor: Tips for navigating the life sciences and regulatory environment
3 years agoThe moral imperative: Balancing innovation, regulation and prescription drug availability
3 years agoIncentivizing diverse representation in clinical trials
3 years ago